Titoli del Settore Sanitario
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 859 | IBRX ImmunityBio, Inc. - Common Stock | 10.00 USD | +0.91% | +0.10% | +22.70% | +300.00% | 10.60 B USD | ||
| 860 | GMED Globus Medical, Inc. Class A Common Stock | 78.84 USD | +3.36% | +7.00% | +3.90% | +34.49% | 10.59 B USD | ||
| 874 | RGEN Repligen Corporation - Common Stock | 184.17 USD | +3.35% | +12.13% | +5.28% | +11.15% | 10.39 B USD | ||
| 876 | ENSG The Ensign Group, Inc. - Common Stock | 178.11 USD | +1.29% | +3.94% | +0.16% | -0.44% | 10.38 B USD | ||
| 880 | OSCR Oscar Health, Inc. Class A Common Stock | 33.48 USD | -2.48% | +0.97% | +0.30% | +64.93% | 10.33 B USD | ||
| 886 | KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 79.94 USD | +1.40% | +2.17% | +1.63% | +101.61% | 10.17 B USD | ||
| 893 | QGEN Qiagen N.V. Common Shares | 46.18 USD | +1.43% | +2.53% | +5.43% | -3.91% | 10.02 B USD | ||
| 903 | GKOS Glaukos Corporation Common Stock | 165.70 USD | -1.26% | +2.56% | +0.62% | +94.46% | 9.77 B USD | ||
| 904 | KRYS Krystal Biotech, Inc. - Common Stock | 330.00 USD | -0.21% | +1.06% | -3.38% | +76.35% | 9.77 B USD | ||
| 905 | BIO Bio-Rad Laboratories, Inc. Class A Common Stock | 364.65 USD | +0.59% | -0.27% | -4.05% | +8.30% | 9.75 B USD | ||
| 908 | PCVX Vaxcyte, Inc. - Common Stock | 65.27 USD | -3.38% | +0.76% | +8.39% | +54.30% | 9.71 B USD | ||
| 909 | HSIC Henry Schein, Inc. - Common Stock | 86.99 USD | +1.67% | +3.42% | -0.02% | +40.10% | 9.69 B USD | ||
| 914 | PODD Insulet Corporation - Common Stock | 138.77 USD | +3.61% | +3.41% | -1.15% | -56.00% | 9.62 B USD | ||
| 924 | TXG 10x Genomics, Inc. - Common Stock | 72.39 USD | -0.97% | -8.55% | -5.27% | +423.81% | 9.43 B USD | ||
| 943 | TWST Twist Bioscience Corporation - Common Stock | 144.49 USD | -2.48% | -5.37% | -4.38% | +381.15% | 9.06 B USD | ||
| 946 | KYMR Kymera Therapeutics, Inc. - Common Stock | 108.14 USD | +1.23% | -1.28% | -9.22% | +82.98% | 8.99 B USD | ||
| 949 | CAI Caris Life Sciences, Inc. - Common Stock | 31.76 USD | +4.96% | +14.16% | +10.74% | +1.60% | 8.98 B USD | ||
| 957 | CYTK Cytokinetics, Incorporated - Common Stock | 63.92 USD | +0.77% | +3.31% | -9.51% | +10.02% | 8.89 B USD | ||
| 960 | PTGX Protagonist Therapeutics, Inc. - Common Stock | 136.55 USD | +0.20% | -2.41% | -5.43% | +81.75% | 8.84 B USD | ||
| 972 | BRKR Bruker Corporation - Common Stock | 56.54 USD | +1.69% | -2.38% | -8.66% | +48.91% | 8.61 B USD |
Notizie Titoli del Settore Sanitario
La CEO di United Therapeutics Rothblatt vende azioni per $5,1 mln
Il CSO di Nurix Therapeutics Gwenn Hansen vende azioni per $36.300
ARK di Cathie Wood vende Amazon, acquista CoreWeave e Iambic
Prime Drink Group lancia finanziamento da C$4M e chiude collocamento da C$200K
Il direttore di Guardant Health Alex M. Azar II vende azioni per $11.032
William Blair avvia la copertura di Cytokinetics con rating outperform
UBS avvia la copertura su Solid Biosciences con rating Buy, annuncia un target price di 20 dollari
Gainers Titoli del Settore Sanitario
ESLA Estrella Immunopharma, Inc. - Common Stock | 0.54 | +68.75% |
DRMA Dermata Therapeutics, Inc. - Common Stock | 0.91 | +37.88% |
INDP Indaptus Therapeutics, Inc. - Common Stock | 2.85 | +28.96% |
HUMA Humacyte, Inc. - Common Stock | 0.44 | +25.71% |
NMRA Neumora Therapeutics, Inc. - Common Stock | 0.43 | +22.86% |
PIIIW P3 Health Partners Inc. - Warrant | 0.0072 | +20.00% |
TRIB Trinity Biotech plc - American Depositary Shares each represent | 7.93 | +19.97% |
AKTX Akari Therapeutics Plc - American Depositary Shares | 8.67 | +19.75% |
Losers Titoli del Settore Sanitario
SPRC SciSparc Ltd. - Ordinary Shares | 2.00 | -44.75% |
CDIOW Cardio Diagnostics Holdings Inc. - Warrant | 0.0064 | -28.09% |
NXGLW NexGel, Inc - Warrant | 0.0065 | -27.78% |
DRTSW Alpha Tau Medical Ltd. - Warrant | 2.9900 | -17.40% |
PFSA Profusa, Inc. - Common Stock | 1.07 | -16.41% |
MDAIW Spectral AI, Inc. - Warrants | 0.4100 | -16.33% |
CDTTW CDT Equity Inc. - Warrant | 0.0061 | -15.28% |
PTN Palatin Technologies, Inc. Common Stock | 6.49 | -15.27% |